Daklinza FDA Approved Drugs
DAKLINZA [Daclatasvir DihydrochlorideC40H50N8O62ClH]
eq 30mg base (oral tablet)
eq 60mg base (oral tablet)
eq 90mg base (oral tablet)
Bristol-myers SquibbJul 24, 2015
- Method of inhibiting hepatitis c virus with daklinza and at least one additional compound having anti-hcv activity.
- Method of inhibiting hepatitis c virus.
WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.